BOLIS, MATTEO MARIA
BOLIS, MATTEO MARIA
Universita' degli Studi di MILANO
Combinatorial strategies targeting NEAT1 and AURKA as new potential therapeutic options for multiple myeloma
2024 N. Puccio, G. Manzotti, E. Mereu, F. Torricelli, D. Ronchetti, M. Cumerlato, I. Craparotta, L.D. Rito, M. Bolis, V. Traini, V. Manicardi, V. Fragliasso, Y. Torrente, N. Amodio, N. Bolli, E. Taiana, A. Ciarrocchi, R. Piva, A. Neri
Safety Profile and Outcomes of Early COVID-19 Treatments in Immunocompromised Patients: A Single-Centre Cohort Study
2022 S. Biscarini, S. Villa, C. Genovese, M. Tomasello, A. Tonizzo, M. Fava, N. Iannotti, M.M. Bolis, B. Mariani, A. Grazia Valzano, L.C. Morlacchi, F. Donato, G. Castellano, R. Cassin, M.D.R. Carrabba, A. Muscatello, A. Gori, A. Bandera, A. Lombardi
Prognostic Value of Mid-Region Proadrenomedullin and In Vitro Interferon Gamma Production for In-Hospital Mortality in Patients with COVID-19 Pneumonia and Respiratory Failure: An Observational Prospective Study
2022 D. Mangioni, M. Oggioni, L. Chatenoud, A. Liparoti, S. Uceda Renteria, L. Alagna, S. Biscarini, M. Bolis, A. Di Modugno, M. Mussa, G. Renisi, R. Ungaro, A. Muscatello, A. Gori, F. Ceriotti, A. Bandera
Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis
2021 N. Pernigoni, E. Zagato, A. Calcinotto, M. Troiani, R.P. Mestre, B. Cali, G. Attanasio, J. Troisi, M. Minini, S. Mosole, A. Revandkar, E. Pasquini, A.R. Elia, D. Bossi, A. Rinaldi, P. Rescigno, P. Flohr, J. Hunt, A. Neeb, L. Buroni, C. Guo, J. Welti, M. Ferrari, M. Grioni, J. Gauthier, R.Z. Gharaibeh, A. Palmisano, G.M. Lucchini, E. D'Antonio, S. Merler, M. Bolis, F. Grassi, A. Esposito, M. Bellone, A. Briganti, M. Rescigno, J.-. Theurillat, C. Jobin, S. Gillessen, J. de Bono, A. Alimonti
Unexpectedly High Frequency of Enterococcal Bloodstream Infections in Coronavirus Disease 2019 Patients Admitted to an Italian ICU: An Observational Study
2020 C. Bonazzetti, V. Morena, A. Giacomelli, L. Oreni, G. Casalini, L.R. Galimberti, M. Bolis, M. Rimoldi, E. Ballone, R. Colombo, A.L. Ridolfo, S. Antinori
Are direct-acting antivirals safe and effective in hepatitis C virus-cryoglobulinemia? virological, immunological, and clinical data from a real-life experience
2018 M. Passerini, M. Schiavini, C.F. Magni, S. Landonio, F. Niero, S. Passerini, A.L. Croci, M. Bolis, V. Scalzi, G. Gubertini, E.D. Ricci, M. Galli, G. Rizzardini
Improvement of ALT decay kinetics by all-oral HCV treatment : role of NS5A inhibitors and differences with IFN-based regimens
2017 V. Cento, T.H.T. Nguyen, D. Di Carlo, E. Biliotti, L. Gianserra, I. Lenci, D. Di Paolo, V. Calvaruso, E. Teti, M. Cerrone, D. Romagnoli, M. Melis, E. Danieli, B. Menzaghi, E. Polilli, M. Siciliano, L.A. Nicolini, A. Di Biagio, C.F. Magni, M. Bolis, F.P. Antonucci, V.C. Di Maio, R. Alfieri, L. Sarmati, P. Casalino, S. Bernardini, V. Micheli, G. Rizzardini, G. Parruti, T. Quirino, M. Puoti, S. Babudieri, A.D. Monforte, M. Andreoni, A. Craxì, M. Angelico, C. Pasquazzi, G. Taliani, J. Guedj, C.F. Perno, F. Ceccherini-Silberstein